ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 20847752

Preclinical evaluation of a gene therapy treatment for transitional cell carcinoma.

Zhang X and 1 other. Cancer Gene Ther, 2011. Cited by 16 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Preclinical evaluation of a gene therapy treatment for transitional cell carcinoma. Papers, record 20847752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20847752

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical evaluation of a gene therapy treatment for transitional cell carcinoma.
PubMed
Journal
Cancer Gene Ther
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang XX
2Godbey WTW T

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Genetic TherapyMajor topic
Animals
BCG Vaccine
Caspase 3
Caspase 9
Celecoxib
Cell Line, Tumor
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Female
Mice
Mice, Inbred C57BL
Promoter Regions, Genetic
Pyrazoles
Sulfonamides

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,566,258Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma.J Thorac Cardiovasc Surg2003https://conductscience.org/library/papers/14566258PubMed
29,630,216Cyclooxygenase regulates angiogenesis induced by colon cancer cells.Cell1998https://conductscience.org/library/papers/9630216PubMed
37,796,280Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse.Surg Oncol Clin N Am1995https://conductscience.org/library/papers/7796280PubMed
418,369,709Intravesical treatments of bladder cancer: review.Pharm Res2008https://conductscience.org/library/papers/18369709PubMed
515,561,779Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.Mol Cancer Res2004https://conductscience.org/library/papers/15561779PubMed
618,413,803Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.Mol Cancer Ther2008https://conductscience.org/library/papers/18413803PubMed
79,929,039COX-2 inhibitors.Lancet1999https://conductscience.org/library/papers/9929039PubMed
812,900,768Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery.Gene Ther2003https://conductscience.org/library/papers/12900768PubMed
910,467,362Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency.Gene Ther1999https://conductscience.org/library/papers/10467362PubMed
108,423,234Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells.J Clin Invest1993https://conductscience.org/library/papers/8423234PubMed

1 to 10 of 49

See all 49 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
29,732,388Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.Bladder Cancer2018https://conductscience.org/library/papers/29732388PubMed
27,119,118Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer.Mol Ther Oncolytics2016https://conductscience.org/library/papers/27119118PubMed
25,054,027Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).Mol Clin Oncol2014https://conductscience.org/library/papers/25054027PubMed
22,458,900Emerging critical role of molecular testing in diagnostic genitourinary pathology.Arch Pathol Lab Med2012https://conductscience.org/library/papers/22458900PubMed
22,218,302Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.Gene Ther2012https://conductscience.org/library/papers/22218302PubMed
22,158,597Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?Nat Rev Urol2011https://conductscience.org/library/papers/22158597PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
PTGS25,743PubTator's text mininghttps://conductscience.org/library/genes/5743NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20847752

GET https://conductscience.org/api/papers/v1/20847752/references?page=2

API referenceFor AI assistants